The BLOC1S2 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population generated from the HT29 human colorectal adenocarcinoma cell line, with targeted disruption of the BLOC1S2 gene. This format provides a heterogeneous pool of loss-of-function cells, enabling robust population-based assays for investigating BLOC1S2-dependent cellular processes such as cargo sorting and vesicle transport.
HT29 cells, originally isolated from a primary colorectal adenocarcinoma of a 44-year-old Caucasian female, are a well-established model of intestinal epithelial cells. They can differentiate into enterocyte-like cells, expressing brush-border enzymes and forming polarized monolayers, making them valuable for studying epithelial trafficking pathways. Although non-melanocytic, HT29 cells retain core trafficking machinery, allowing investigation of BLOC1S2 function in an epithelial context.
BLOC1S2 is an essential subunit of the BLOC-1 complex, which orchestrates cargo sorting from early endosomes to maturing lysosome-related organelles. BLOC1S2 interacts with other subunits, including dysbindin, pallidin, muted, and snapin, and functionally cooperates with the AP-3 complex to traffic melanosomal proteins such as TYR and TYRP1. MITF transcriptionally regulates BLOC1S2 in melanocytes. Loss of BLOC1S2 disrupts BLOC-1 assembly, impairing melanosome biogenesis and platelet dense granule formation, causing Hermansky-Pudlak syndrome type 9.
In the HT29 adenocarcinoma background, BLOC1S2 knockout permits dissection of BLOC-1 cell-autonomous functions in an epithelial setting. HT29 cells express AP-3 pathway components and other trafficking factors, enabling analysis of BLOC-1 complex integrity, endosomal sorting, and organelle dynamics. This model is particularly useful for elucidating how BLOC-1 dysfunction impacts epithelial cell biology, protein secretion, and lysosome-related organelle homeostasis. The enterocyte-like differentiation capability allows examination of BLOC1S2??s role in intestinal organelle biogenesis or specialized secretion.
This knockout cell product supports a broad range of applications, including the study of Hermansky-Pudlak syndrome, vesicular trafficking, and organelle biogenesis. Typical assays include western blotting for BLOC1S2 and associated subunits, immunofluorescence microscopy for LAMP1 to assess lysosomal compartments, co-immunoprecipitation to probe BLOC-1 complex interactions, RT-qPCR for downstream targets TYR and TYRP1, and flow cytometry for surface integrin expression. Under appropriate differentiation conditions, platelet aggregation assays and electron microscopy for dense granule ultrastructure can be employed. The polyclonal population is also applicable to drug screening campaigns aimed at correcting trafficking defects. For additional support or custom cell engineering, please contact Ascent Research.
